EXT2 Antikörper
Kurzübersicht für EXT2 Antikörper (ABIN7114020)
Target
Alle EXT2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Immunogen affinity purified
-
Reinheit
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- exostoses(multiple) 2
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:500-1:2000, IHC: 1:20-1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
-
Haltbarkeit
- 12 months
-
-
- EXT2 (Exostosin 2 (EXT2))
-
Andere Bezeichnung
- EXT2
-
Hintergrund
- Synonyms:exostoses (multiple) 2, Exostosin 2, EXT2, Multiple exostoses protein 2, SOTV Background:Glycosyltransferase required for the biosynthesis of heparan-sulfate. The EXT1/EXT2 complex possesses substantially higher glycosyltransferase activity than EXT1 or EXT2 alone. Appears to be a tumor suppressor. Required for the exosomal release of SDCBP, CD63 and syndecan(PubMed:22660413).
-
Molekulargewicht
- 82kd
-
Gen-ID
- 2132
-
UniProt
- Q93063
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-